huahaipharm(SH:600521) Shang Hai Zheng Quan Bao·2025-04-18 23:21Core Viewpoint - Zhejiang Huahai Pharmaceutical Co., Ltd. announced a potential downward adjustment of the conversion price for its convertible bonds due to the stock price falling below 80% of the current conversion price for 10 out of 30 trading days [2][7]. Group 1: Convertible Bond Overview - The company issued 18.426 million convertible bonds on November 2, 2020, with a total amount of 1.8426 billion yuan [3]. - The bonds are listed on the Shanghai Stock Exchange under the name "Huahai Convertible Bonds" with the code 110076, and have a maturity period of six years [3]. Group 2: Downward Adjustment Terms - The board has the authority to propose a downward adjustment of the conversion price if the stock price is below 80% of the current conversion price for at least 15 out of 30 consecutive trading days [4]. - The adjusted conversion price must not be lower than the average trading price of the stock over the 20 trading days prior to the shareholders' meeting and must also meet certain asset value criteria [4]. Group 3: Adjustment Procedure - If the conversion price is to be adjusted, the company must publish a resolution announcement detailing the adjustment, record date, and suspension of conversion period [5]. - The adjusted conversion price will take effect on the first trading day following the record date [6]. Group 4: Trigger Conditions - From April 4 to April 18, 2025, the company's stock closed below the current conversion price of 33.21 yuan for 10 trading days, indicating a potential trigger for the downward adjustment [7]. - The company is required to disclose its decision regarding the adjustment on the trading day following the board meeting [7].